Leukemia​

Imalar ® is indicated for the treatment of: ​

• Chronic myeloid leukaemia (CML). ​
• Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph-positive ALL).​
• Myelodysplastic/myeloproliferative diseases (MDS/MPD).​
• Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL). ​

​

Strength:​

100 mg​

400 mg​

​

Dosage Form:​

Film-Coated Tablets​

​

Active ingredient:​

Imatinib​

Azacitidine SPC® is used in adults who are not able to have a stem cell transplantation to treat:​

myelodysplastic syndromes (MDS).​

acute myeloid leukaemia (AML)​

Acute myeloid leukaemia (AML).​

​

Strength:​

100 mg​

​

Dosage Form:​

Powder for Solution for Injection​

​

Active ingredient:​

Azacitidine​

Ensutine® is used for the treatment of chronic lymphocyticleukaemia in cases where fludarabine combination chemotherapy isnot appropriate for you.​

​

Strength:​

180 mg/4 ml​

​

Dosage Form:​

Concentrate for solution for infusion ​

​

Active ingredient:​

Bendamustine hydrochloride​

CEKEA® is indicated for the treatment of: ​

Chronic myeloid leukaemia (CML) ​

Cervical cancer ​

​

Strength:​

200 mg​

500 mg​

​

Dosage Form:​

capsules​

​

Active ingredient:​

Hydroxyurea (Hydroxycarbamide)​

Otrasa® is indicated for the treatment of adult & Paediatric patients with: ​

Chronic myelogenous leukaemia (CML) ​

Philadelphia chromosome positive (Ph+) Acute lymphoblastic leukaemia (ALL)​

​

Strength:​

50 mg​

70 mg​

100 mg​

​

Dosage Form:​

Film-Coated Tablets​

​

Active ingredient:​

Dasatinib​